Medicines Australia Supports Robust Global Standard Of Industry Conduct

Main Category: Pharma Industry / Biotech Industry
Article Date: 03 Nov 2007 - 1:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:not yet rated


Medicines Australia strongly supports the establishment of a robust global standard of industry conduct, chief executive Ian Chalmers said recently.

Mr Chalmers was responding to the release of a report produced by Consumers International on the pharmaceutical industry's marketing practices.

"This report is about marketing practices in developing countries," Mr Chalmers said.

"Medicines Australia has no jurisdiction over the practices of overseas pharmaceutical companies.

"However, what Medicines Australia can do - and is doing - is to lead by example, demonstrating our strong commitment to the highest ethical standards.

"This is an area in which Medicines Australia is showing resolute leadership. We are already working actively with an IFPMA [International Federation of Pharmaceutical Manufacturers and Associations] code communication network to encourage a robust global standard for Codes of Conduct throughout IFPMA member countries.

"For example, we have given presentations at two international industry meetings this year, in Singapore and Hong Kong, aimed at advising and assisting companies in Asia-Pacific countries in bringing their Codes of Conduct up to the IFPMA standard.

"The fact is that in Australia, pharmaceutical companies set a very high bar in terms of business ethics. Medicines Australia member companies are bound by a strict Code of Conduct, which prohibits gifts, entertainment and extravagant hospitality - as does the IFPMA Code of Conduct.

"In Australia we don't use direct-to-consumer advertising to promote medicines, we work cooperatively within an extremely robust and effective regulatory framework, and we're committed to transparency.

"It's important to remember that our industry exists to help make people better. Our priority is to ensure Australians have timely and affordable access to medicines that are appropriate, effective and safe."

http://www.medicinesaustralia.com.au

Article adapted by Medical News Today from original press release.
Visit our pharma industry / biotech industry section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Medicines Australia. "Medicines Australia Supports Robust Global Standard Of Industry Conduct." Medical News Today. MediLexicon, Intl., 3 Nov. 2007. Web.
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/87283.php>

APA
Medicines Australia. (2007, November 3). "Medicines Australia Supports Robust Global Standard Of Industry Conduct." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/87283.php.

Please note: If no author information is provided, the source is cited instead.


Pharma Industry / Biotech Industry

Most Popular Articles



Follow Our Pharma Industry News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Pharma Industry / Biotech Industry Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »